1.Polyomavirus (BK Virus) Nephropathy in Kidney Transplant Patients: A Pathologic Perspective.
Yonsei Medical Journal 2004;45(6):1065-1075
Reactivation of polyoma virus (BK virus) is a significant cause of morbidity in kidney transplant patients. This seemingly insignificant viral infection that affects the majority of population at a young age, once reactivated by immunosuppression, is a major factor contributing to graft loss. Screening techniques have been developed for early prediction of BK virus reactivation. These include plasma and urine assays for detection of BK virus DNA by PCR, urine cytology for detection of "decoy cells" and electron microscopy. Combining urine cytology and serology screening can be more effective for early detection of BK virus reactivation. Immunohistochemistry can be utilized as an additional tool to support the diagnosis. Once screening tests reveal a suspicious BK virus reactivation, tissue biopsy should be performed to confirm the diagnosis, rule out acute cellular rejection and plan treatment approaches. Treatment normally includes decreasing immunosuppression and the use of antiviral drug therapy. Unfortunately, disease outcome is often unfavorable and can culminate with eventual graft loss. Renal retransplantation has been performed with mixed results. As new data emerges, we will gain a better understanding of the disease caused by BK virus and respond with improved early diagnosis and treatment to preserve graft function.
Antiviral Agents/therapeutic use
;
*BK Virus
;
Humans
;
Immunosuppression/*adverse effects
;
Kidney Diseases/pathology/*virology
;
*Kidney Transplantation
;
Polyomavirus Infections/*complications/drug therapy/etiology
;
Tumor Virus Infections/*complications/drug therapy/etiology
2.Impact of Combined Acute Rejection on BK Virus-Associated Nephropathy in Kidney Transplantation.
Yoon Jung KIM ; Jong Cheol JEONG ; Tai Yeon KOO ; Hyuk Yong KWON ; Miyeun HAN ; Hee Jung JEON ; Curie AHN ; Jaeseok YANG
Journal of Korean Medical Science 2013;28(12):1711-1715
BK virus-associated nephropathy (BKVAN) is one of the major causes of allograft dysfunction in kidney transplant (KT) patients. We compared BKVAN combined with acute rejection (BKVAN/AR) with BKVAN alone in KT patients. We retrospectively analyzed biopsy-proven BKVAN in KT patients from 2000 to 2011 at Seoul National University Hospital. Among 414 biopsies from 951 patients, biopsy-proven BKVAN was found in 14 patients. Nine patients had BKVAN alone, while 5 patients had both BKVAN and acute cellular rejection. BKVAN in the BKVAN alone group was detected later than in BKVAN/AR group (21.77 vs 6.39 months after transplantation, P=0.03). Serum creatinine at diagnosis was similar (2.09 vs 2.00 mg/dL). Histological grade was more advanced in the BKVAN/AR group (P=0.034). Serum load of BKV, dose of immunosuppressants, and tacrolimus level showed a higher tendency in the BKVAN alone group; however it was not statistically significant. After anti-rejection therapy, immunosuppression was reduced in the BKVAN/AR group. Renal functional deterioration over 1 yr after BKVAN diagnosis was similar between the two groups (P=0.665). These findings suggest that the prognosis of BKVAN/AR after anti-rejection therapy followed by anti-BKV therapy might be similar to that of BKVAN alone after anti-BKV therapy.
Acute Disease
;
Adult
;
Antiviral Agents/therapeutic use
;
BK Virus/*physiology
;
Creatinine/blood
;
Female
;
*Graft Rejection/diagnosis/virology
;
Humans
;
Immunosuppressive Agents/administration & dosage
;
Kidney/*virology
;
Kidney Diseases/pathology/surgery/*virology
;
*Kidney Transplantation
;
Male
;
Middle Aged
;
Polyomavirus Infections/drug therapy/*etiology/pathology
;
Retrospective Studies
;
Tacrolimus/administration & dosage
;
Time Factors
;
Transplantation, Homologous/adverse effects
;
Tumor Virus Infections/drug therapy/*etiology/pathology